Cargando…
Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase
Clinically relevant disease-causing variants of the human dihydrolipoamide dehydrogenase (hLADH, hE3), a common component of the mitochondrial α-keto acid dehydrogenase complexes, were characterized using a multipronged approach to unravel the molecular pathomechanisms that underlie hLADH deficiency...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341545/ https://www.ncbi.nlm.nih.gov/pubmed/37446004 http://dx.doi.org/10.3390/ijms241310826 |
_version_ | 1785072287384338432 |
---|---|
author | Szabo, Eszter Nemes-Nikodem, Eva Vass, Krisztina Rubina Zambo, Zsofia Zrupko, Eszter Torocsik, Beata Ozohanics, Oliver Nagy, Balint Ambrus, Attila |
author_facet | Szabo, Eszter Nemes-Nikodem, Eva Vass, Krisztina Rubina Zambo, Zsofia Zrupko, Eszter Torocsik, Beata Ozohanics, Oliver Nagy, Balint Ambrus, Attila |
author_sort | Szabo, Eszter |
collection | PubMed |
description | Clinically relevant disease-causing variants of the human dihydrolipoamide dehydrogenase (hLADH, hE3), a common component of the mitochondrial α-keto acid dehydrogenase complexes, were characterized using a multipronged approach to unravel the molecular pathomechanisms that underlie hLADH deficiency. The G101del and M326V substitutions both reduced the protein stability and triggered the disassembly of the functional/obligate hLADH homodimer and significant FAD losses, which altogether eventually manifested in a virtually undetectable catalytic activity in both cases. The I12T-hLADH variant proved also to be quite unstable, but managed to retain the dimeric enzyme form; the LADH activity, both in the forward and reverse catalytic directions and the affinity for the prosthetic group FAD were both significantly compromised. None of the above three variants lent themselves to an in-depth structural analysis via X-ray crystallography due to inherent protein instability. Crystal structures at 2.89 and 2.44 Å resolutions were determined for the I318T- and I358T-hLADH variants, respectively; structure analysis revealed minor conformational perturbations, which correlated well with the residual LADH activities, in both cases. For the dimer interface variants G426E-, I445M-, and R447G-hLADH, enzyme activities and FAD loss were determined and compared against the previously published structural data. |
format | Online Article Text |
id | pubmed-10341545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103415452023-07-14 Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase Szabo, Eszter Nemes-Nikodem, Eva Vass, Krisztina Rubina Zambo, Zsofia Zrupko, Eszter Torocsik, Beata Ozohanics, Oliver Nagy, Balint Ambrus, Attila Int J Mol Sci Article Clinically relevant disease-causing variants of the human dihydrolipoamide dehydrogenase (hLADH, hE3), a common component of the mitochondrial α-keto acid dehydrogenase complexes, were characterized using a multipronged approach to unravel the molecular pathomechanisms that underlie hLADH deficiency. The G101del and M326V substitutions both reduced the protein stability and triggered the disassembly of the functional/obligate hLADH homodimer and significant FAD losses, which altogether eventually manifested in a virtually undetectable catalytic activity in both cases. The I12T-hLADH variant proved also to be quite unstable, but managed to retain the dimeric enzyme form; the LADH activity, both in the forward and reverse catalytic directions and the affinity for the prosthetic group FAD were both significantly compromised. None of the above three variants lent themselves to an in-depth structural analysis via X-ray crystallography due to inherent protein instability. Crystal structures at 2.89 and 2.44 Å resolutions were determined for the I318T- and I358T-hLADH variants, respectively; structure analysis revealed minor conformational perturbations, which correlated well with the residual LADH activities, in both cases. For the dimer interface variants G426E-, I445M-, and R447G-hLADH, enzyme activities and FAD loss were determined and compared against the previously published structural data. MDPI 2023-06-28 /pmc/articles/PMC10341545/ /pubmed/37446004 http://dx.doi.org/10.3390/ijms241310826 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Szabo, Eszter Nemes-Nikodem, Eva Vass, Krisztina Rubina Zambo, Zsofia Zrupko, Eszter Torocsik, Beata Ozohanics, Oliver Nagy, Balint Ambrus, Attila Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title | Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title_full | Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title_fullStr | Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title_full_unstemmed | Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title_short | Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase |
title_sort | structural and biochemical investigation of selected pathogenic mutants of the human dihydrolipoamide dehydrogenase |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341545/ https://www.ncbi.nlm.nih.gov/pubmed/37446004 http://dx.doi.org/10.3390/ijms241310826 |
work_keys_str_mv | AT szaboeszter structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT nemesnikodemeva structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT vasskrisztinarubina structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT zambozsofia structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT zrupkoeszter structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT torocsikbeata structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT ozohanicsoliver structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT nagybalint structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase AT ambrusattila structuralandbiochemicalinvestigationofselectedpathogenicmutantsofthehumandihydrolipoamidedehydrogenase |